glp-1 and fatty liver disease Pioglitazone with SGLT2 inhibitors or receptor agonists in patients with type 2 diabetes non-alcoholic disease: could the combinations of an old friend with new players yield better outcomes? GLP-1 Shows Promise for Patients

Ideal Nutrition takes the guesswork out by pre-counting macros in each meal - you simply choose your plan and enjoy

Tiers 46 cover specialty drugs, biologics, and non-formulary drugs, often with coinsurance rather than a flat copay meaning patient out-of-pocket costs can reach thousands of dollars per fill

10.1111/apt.16451 54 KusunokiH.HarumaK.ManabeN.ImamuraH.KamadaT.ShiotaniA.et al (2012)

The gap between choosing the right compound and wasting months on protocols that don't match the biological question comes down to understanding what each molecule actually does at the receptor level

Article 11 mins SEC Issues Additional Compliance and Disclosure Interpretations on Pay Versus Performance Disclosure The SEC published nine new Compliance and Disclosure Interpretations (C&DIs) covering the pay versus performance rule

There seems to be a trend among physicians that nutrients, vitamins, and supplements have no place in the treatment of patients when in reality they can be an amazing part of a complete treatment plan